|
|
 |
|
Total Number of Holdings (excluding cash): 50
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$94,855.23 |
3.03% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$94,154.67 |
3.00% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$89,722.96 |
2.86% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$85,804.38 |
2.74% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$84,979.61 |
2.71% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$82,457.13 |
2.63% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$81,482.88 |
2.60% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$80,728.14 |
2.58% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$80,089.27 |
2.55% |
| Waters Corporation |
WAT |
941848103 |
184 |
$78,336.16 |
2.50% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$77,705.36 |
2.48% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$76,931.67 |
2.45% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$75,392.64 |
2.41% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$74,468.87 |
2.38% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$73,780.60 |
2.35% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$69,906.00 |
2.23% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$69,710.54 |
2.22% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$68,537.90 |
2.19% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$67,429.35 |
2.15% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$67,206.46 |
2.14% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$67,084.20 |
2.14% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$65,840.35 |
2.10% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$65,533.13 |
2.09% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$63,408.70 |
2.02% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$62,200.20 |
1.98% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$61,360.52 |
1.96% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$60,969.72 |
1.94% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$59,489.34 |
1.90% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$57,268.26 |
1.83% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$57,080.90 |
1.82% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$56,851.42 |
1.81% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$56,477.10 |
1.80% |
| Steris Plc |
STE |
G8473T100 |
265 |
$55,329.35 |
1.77% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$53,479.89 |
1.71% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$52,271.70 |
1.67% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$52,118.60 |
1.66% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$51,858.21 |
1.65% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$49,536.92 |
1.58% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$49,023.88 |
1.56% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$48,596.67 |
1.55% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$48,346.60 |
1.54% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$47,865.66 |
1.53% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$46,795.99 |
1.49% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$45,780.12 |
1.46% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,554.23 |
1.42% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$42,898.60 |
1.37% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$42,218.78 |
1.35% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$41,814.00 |
1.33% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$41,623.72 |
1.33% |
| US Dollar |
$USD |
|
12,931 |
$12,931.05 |
0.41% |
| Australian Dollar |
$AUD |
|
601 |
$427.53 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|